Universe Pharmaceuticals (UPC) Short-term Investments (2021 - 2026)

Universe Pharmaceuticals has reported Short-term Investments for 5 years, with the latest figure at $1.5 million in Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed N/A YoY) and the FY2024 annual result came in at $1.4 billion, up 100691.56% from the prior year.
• Short-term Investments declined to $1.5 million in Q1 2026 per UPC's latest filing, from $1.4 billion in the prior quarter.
• Over five years, Short-term Investments peaked at $1.4 billion in Q3 2024 and troughed at -$696430.0 in Q1 2022.
• A 4-year average of $201.3 million and a median of $2.5 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments plunged 89.6% in 2023, then jumped 100691.56% in 2024.
• Over 4 years, Short-term Investments stood at $13.1 million in 2022, then slumped by 89.6% to $1.4 million in 2023, then surged by 100691.56% to $1.4 billion in 2024, then tumbled by 99.89% to $1.5 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $1.5 million, $1.4 billion, and $2.5 million for Q1 2026, Q3 2024, and Q1 2024 respectively.